Open Access
Issue
J Oral Med Oral Surg
Volume 30, Number 2, 2024
Article Number 13
Number of page(s) 6
DOI https://doi.org/10.1051/mbcb/2024016
Published online 18 July 2024
  1. Choi JH, Ro JY. The 2020 WHO classification of tumors of soft tissue: selected changes and new entities. Adv Anat Pathol 2021;28:44–58. [CrossRef] [PubMed] [Google Scholar]
  2. Alexiev BA. Pathology outlines − giant cell tumor of bone, NOS [Internet. Accessed May 17th, 2024. https://www.pathologyoutlines.com/topic/bonegiantcelltumor.html [Google Scholar]
  3. Saad F, Brown JE, Van Poznak C, Ibrahim T, Stemmer SM, Stopeck AT, et al. Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases. Annal Oncol 2012;23:1341–1347. [CrossRef] [Google Scholar]
  4. Dodson TB. The frequency of medication-related osteonecrosis of the jaw and its associated risk factors. Oral Maxillofac Surg Clin North Am 2015;27:509–516. [CrossRef] [PubMed] [Google Scholar]
  5. Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D. American association of oral and maxillofacial surgeons' position paper on medication-related osteonecrosis of the jaws—2022 update. J Oral Maxillofac Surg 2022;80:920–943. [CrossRef] [PubMed] [Google Scholar]
  6. Kim JW, Baik J, Jeon JH. Dental implant treatment after healing of bisphosphonate-related osteonecrosis of the jaw (BRONJ) in the same region: a case report. J Korean Assoc Oral Maxillofac Surg 2016;42:157. [CrossRef] [PubMed] [Google Scholar]
  7. Rugani P, Kirnbauer B, Acham S, Truschnegg A, Jakse N. Implant placement adjacent to successfully treated bisphosphonate-related osteonecrosis of the jaw (BRONJ). J Oral Implantol 2015;41:377–381. [CrossRef] [PubMed] [Google Scholar]
  8. Aghaloo T, Hazboun R, Tetradis S. Pathophysiology of osteonecrosis of the jaws. Oral Maxillofac Surg Clin North Am 2015;27:489–496. [CrossRef] [PubMed] [Google Scholar]
  9. Duarte NT, Rech B de O, Martins IG, Franco JB, Ortega KL. Can children be affected by bisphosphonate-related osteonecrosis of the jaw? A systematic review. Int J Oral Maxillofac Surg 2020;49: 183–191. [CrossRef] [Google Scholar]
  10. Gupta A, Durocher-Allen L, Popovic S, Tozer R, Yao X, Ghert M. The role of denosumab for surgical outcomes in patients with giant cell tumour of bone: a systematic review. Curr Oncol 2021;28: 1302–1313. [CrossRef] [PubMed] [Google Scholar]
  11. Scoccianti G, Totti F, Scorianz M, Baldi G, Roselli G, Beltrami G, et al. Preoperative denosumab with curettage and cryotherapy in giant cell tumor of bone: is there an increased risk of local recurrence? Clin Orthop Relat Res 2018;476:1783–1790. [CrossRef] [PubMed] [Google Scholar]
  12. Palmerini E, Chawla NS, Ferrari S, Sudan M, Picci P, Marchesi E, et al. Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): for how long? Eur J Cancer 2017;76: 118–124. [CrossRef] [PubMed] [Google Scholar]
  13. Chawla S, Blay JY, Rutkowski P, Le Cesne A, Reichardt P, Gelderblom H, et al. Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study. Lancet Oncol 2019;20:1719–1729. [CrossRef] [PubMed] [Google Scholar]
  14. Kawahara M, Kuroshima S, Sawase T. Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review. Int J Implant Dent 2021;7:47. [CrossRef] [PubMed] [Google Scholar]
  15. Walter C, Al-Nawas B, Wolff T, Schiegnitz E, Grötz KA. Dental implants in patients treated with antiresorptive medication − a systematic literature review. Int J Implant Dent 2016;2:9. [CrossRef] [PubMed] [Google Scholar]
  16. Sher J, Kirkham-Ali K, Luo JD, Miller C, Sharma D. Dental implant placement in patients with a history of medications related to osteonecrosis of the jaws: a systematic review. J Oral Implantol 2020;47:249–268. [Google Scholar]
  17. Watts NB, Grbic JT, Binkley N, Papapoulos S, Butler PW, Yin X, et al. Invasive oral procedures and events in postmenopausal women with osteoporosis treated with denosumab for up to 10 years. J Clin Endocrinol Metab 2019;104:2443–2452. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.